ckd-341
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Nov 2, 2022 (NCT05571813)
Timeline
2020s
- Jan 1, 2022
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06281132 | Phase 1 | Mar 22, 2024 | Chong Kun Dang Pharmaceutical |
| NCT05921435 | Phase 1 | Jun 19, 2023 | Chong Kun Dang Pharmaceutical |
| NCT05571813 | Phase 1 | Nov 2, 2022 | Chong Kun Dang Pharmaceutical |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Chong Kun Dang Pharmaceutical | For profit | 3 | 3 | 1 | 2022 |
1 organizations
Page 1 / 1